In this issue:
Transdermal oestradiol for locally advanced prostate cancer
On-treatment serum PSA and OS in prostate cancer
Salvage focal therapy vs radical prostatectomy for radiorecurrent cancer
Radiographic progression with and without PSA rise
Oxybutynin for hot flashes during ADT
Relapse-free survival with ADT, radiotherapy, docetaxel and estramustine
Immunohistochemical PSMA expression patterns
Pain and HRQoL outcomes with darolutamide in mHSPC
Radiation, hormone, and immunotherapy for grade group 5 prostate cancer
Enzalutamide + radium-223 in mCRPC
Please login below to download this issue (PDF)